| scholarly article | Q13442814 |
| P50 | author | Giulia Murtas | Q54963175 |
| Loredano Pollegioni | Q28359654 | ||
| P2093 | author name string | Silvia Sacchi | |
| P2860 | cites work | Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: potential relevance to Alzheimer's disease | Q48268722 |
| Free D-serine, D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase | Q48305063 | ||
| Involvement of the primate specific gene G72 in schizophrenia: From genetic studies to pathomechanisms | Q48324392 | ||
| An Improved Drugs Screening System Reveals that Baicalein Ameliorates the Aβ/AMPA/NMDA-Induced Depolarization of Neurons | Q48348242 | ||
| Involvement of D-amino acid oxidase in elimination of D-serine in mouse brain | Q48444964 | ||
| Age-related effects of the neuromodulator D-serine on neurotransmission and synaptic potentiation in the CA1 hippocampal area of the rat. | Q48491445 | ||
| Regional distribution and postnatal changes of D-amino acids in rat brain | Q48763751 | ||
| Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase | Q48857138 | ||
| Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine. | Q48925158 | ||
| D-Amino Acid Oxidase-pLG72 Interaction and D-Serine Modulation. | Q50127100 | ||
| Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia | Q22241679 | ||
| d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia | Q24294371 | ||
| Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis | Q24297316 | ||
| A proteome-wide perspective on peroxisome targeting signal 1(PTS1)-Pex5p affinities | Q24300660 | ||
| Evidence for the interaction of D-amino acid oxidase with pLG72 in a glial cell line | Q24306641 | ||
| Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia | Q24308818 | ||
| Relevance of weak flavin binding in human D-amino acid oxidase | Q24309227 | ||
| Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment | Q24316880 | ||
| Characterization of human D-amino acid oxidase | Q24317569 | ||
| pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility | Q24320365 | ||
| NMDA Receptor Function During Senescence: Implication on Cognitive Performance | Q26770902 | ||
| Sites of binding and orientation in a four-location model for protein stereospecificity | Q27625401 | ||
| The x-ray structure of D-amino acid oxidase at very high resolution identifies the chemical mechanism of flavin-dependent substrate dehydrogenation | Q27628036 | ||
| Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System. | Q50482411 | ||
| Elucidation of inhibitor-binding pockets of d-amino acid oxidase using docking simulation and N-sulfanylethylanilide-based labeling technology. | Q50998776 | ||
| Modulating D-amino acid oxidase (DAAO) substrate specificity through facilitated solvent access. | Q55283538 | ||
| Biochemical Properties of Human D-amino Acid Oxidase Variants and Their Potential Significance in Pathologies. | Q55340063 | ||
| DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia. | Q55717695 | ||
| Immunocytochemical localization of D-amino acid oxidase in rat brain | Q58236646 | ||
| The role of cofactor binding in tryptophan accessibility and conformational stability of His-tagged d-amino acid oxidase from Trigonopsis variabilis | Q59385642 | ||
| Localization of D-amino acid oxidase mRNA in the mouse kidney and the effect of testosterone treatment | Q70934129 | ||
| Characterization of D-amino acid oxidase from Trigonopsis variabilis | Q72666242 | ||
| D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes | Q72788226 | ||
| Regulation of rat magnocellular neurosecretory system by D-aspartate: evidence for biological role(s) of a naturally occurring free D-amino acid in mammals | Q73131335 | ||
| Nephrotoxicity of D-proparglyglycine in mice | Q73245807 | ||
| Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance | Q87223869 | ||
| Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia | Q94704034 | ||
| Yeast D-amino acid oxidase: structural basis of its catalytic properties | Q27640004 | ||
| Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors | Q27655460 | ||
| Novel human ᴅ-amino acid oxidase inhibitors stabilize an active-site lid-open conformation | Q27684575 | ||
| Crystal structure of D-amino acid oxidase: a case of active site mirror-image convergent evolution with flavocytochrome b2 | Q27733284 | ||
| Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia | Q28274560 | ||
| Physiological functions of D-amino acid oxidases: from yeast to humans | Q28295729 | ||
| Serine racemase modulates intracellular D-serine levels through an alpha,beta-elimination activity | Q28513330 | ||
| A critical role for the glial-derived neuromodulator D-serine in the age-related deficits of cellular mechanisms of learning and memory | Q28571166 | ||
| Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission | Q28590312 | ||
| BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology | Q28603124 | ||
| Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-D-aspartate receptor-mediated synaptic transmission in mutant mice lacking D-amino-acid oxidase | Q31680371 | ||
| The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. | Q33611796 | ||
| Activity of D-amino acid oxidase is widespread in the human central nervous system | Q33730910 | ||
| Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase | Q33842154 | ||
| Neurobiology through the looking-glass: D-serine as a new glial-derived transmitter | Q33960838 | ||
| Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. | Q33966453 | ||
| Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients | Q33987618 | ||
| D-amino acids in the central nervous system in health and disease | Q33988102 | ||
| Metabolism of amino-acids: Deamination of amino-acids | Q33996419 | ||
| Glutamate and schizophrenia: beyond the dopamine hypothesis | Q33996803 | ||
| Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). | Q33997506 | ||
| Why is D-serine nephrotoxic and alpha-aminoisobutyric acid protective? | Q34003528 | ||
| Mouse mutant deficient in D-amino acid oxidase activity | Q34005267 | ||
| Metabolism of the neuromodulator D-serine. | Q34021473 | ||
| The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: a review | Q34033121 | ||
| Drug discovery targeting amino acid racemases | Q34215943 | ||
| Effects of D-amino acid oxidase inhibition on memory performance and long-term potentiation in vivo | Q34286452 | ||
| d-serine levels in Alzheimer's disease: implications for novel biomarker development | Q34475073 | ||
| Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. | Q43648615 | ||
| Assignment of D-amino-acid oxidase gene to a human and a mouse chromosome | Q43673577 | ||
| A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 | ||
| Spinal D-amino acid oxidase contributes to mechanical pain hypersensitivity induced by sleep deprivation in the rat. | Q44590316 | ||
| Structure-function correlation in glycine oxidase from Bacillus subtilis. | Q44856933 | ||
| Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain | Q45780324 | ||
| Determination of D-serine and D-alanine in the tissues and physiological fluids of mice with various D-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection. | Q45935284 | ||
| Optimization of human D-amino acid oxidase expression in Escherichia coli. | Q45982397 | ||
| Synthesis and biological evaluation of D-amino acid oxidase inhibitors. | Q46572073 | ||
| D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity | Q46813951 | ||
| Competitive Inhibitors Unveil Structure/Function Relationships in Human D-Amino Acid Oxidase | Q47117950 | ||
| Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons | Q47118571 | ||
| Human d-amino acid oxidase: The inactive G183R variant | Q47258168 | ||
| Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target | Q47681604 | ||
| Biochemical Properties of Human D-Amino Acid Oxidase. | Q47868455 | ||
| Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro | Q48172184 | ||
| d-Amino Acid Levels in Perfused Mouse Brain Tissue and Blood: A Comparative Study | Q48229603 | ||
| L-serine and glycine serve as major astroglia-derived trophic factors for cerebellar Purkinje neurons | Q35313612 | ||
| Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways | Q35624305 | ||
| Expanding the chemical space of human serine racemase inhibitors | Q35748414 | ||
| Protective role of D-amino acid oxidase against Staphylococcus aureus infection | Q35867584 | ||
| Novel insights into renal D-amino acid oxidase accumulation: propiverine changes DAAO localization and peroxisomal size in vivo | Q35951912 | ||
| D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain | Q36025408 | ||
| Localization of D-amino acid oxidase on the cell surface of human polymorphonuclear leukocytes | Q36199108 | ||
| Understanding renal nuclear protein accumulation: an in vitro approach to explain an in vivo phenomenon | Q36357444 | ||
| D-amino acid oxidase in leukocytes: a possible D-amino-acid-linked antimicrobial system | Q36450594 | ||
| Crystal structure of human D-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. | Q36458171 | ||
| Novel targets for drugs in schizophrenia | Q36907403 | ||
| Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase | Q36917482 | ||
| Human D-amino acid oxidase: an update and review. | Q36965925 | ||
| Properties and applications of microbial D-amino acid oxidases: current state and perspectives | Q37033904 | ||
| D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain | Q37118079 | ||
| Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota | Q37357830 | ||
| Central sensitization: a generator of pain hypersensitivity by central neural plasticity | Q37361185 | ||
| Serine racemase and the serine shuttle between neurons and astrocytes | Q37827616 | ||
| New biotech applications from evolved D-amino acid oxidases. | Q37852361 | ||
| Structure-function relationships in human D-amino acid oxidase. | Q38032223 | ||
| The serine shuttle between glia and neurons: implications for neurotransmission and neurodegeneration. | Q38164385 | ||
| D-amino acid oxidase activity is inhibited by an interaction with bassoon protein at the presynaptic active zone. | Q38672905 | ||
| Elucidating the role of the pLG72 R30K substitution in schizophrenia susceptibility | Q38717701 | ||
| G72 primate-specific gene: a still enigmatic element in psychiatric disorders | Q38749650 | ||
| Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs | Q38907627 | ||
| The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. | Q39062810 | ||
| Characterization of human DAAO variants potentially related to an increased risk of schizophrenia. | Q39230935 | ||
| Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction | Q39613722 | ||
| In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties | Q40097342 | ||
| Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells | Q40349429 | ||
| High-Throughput Screening Strategy Identifies Allosteric, Covalent Human D-Amino Acid Oxidase Inhibitor | Q40618357 | ||
| Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies | Q41619176 | ||
| Ischemic acute kidney injury perturbs homeostasis of serine enantiomers in the body fluid in mice: early detection of renal dysfunction using the ratio of serine enantiomers | Q41898653 | ||
| A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats. | Q42856729 | ||
| D-amino acid oxidase activity and expression are increased in schizophrenia. | Q43195422 | ||
| Spinal D-amino acid oxidase contributes to neuropathic pain in rats | Q43261398 | ||
| Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain | Q43291010 | ||
| The presence of free D-serine, D-alanine and D-proline in human plasma | Q43586675 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 107 | |
| P577 | publication date | 2018-11-28 | |
| P1433 | published in | Frontiers in molecular biosciences | Q27726420 |
| P1476 | title | Human D-Amino Acid Oxidase: Structure, Function, and Regulation | |
| P478 | volume | 5 |
| Q91675920 | Substitution of Arginine 120 in Human D-Amino Acid Oxidase Favors FAD-Binding and Nuclear Mistargeting | cites work | P2860 |
Search more.